Hello Blucken-ga,
Thank you for your question.
Global:
According to this Nov 2000 article that appeared in the European
Pharmaceutical Review, by Edward H. Erickson, Division Vice President,
3M Drug Delivery Systems Division, the current worldwide transdermal
market is approximately $2.2 billion and is expected to grow at least
10 to 12 percent annually.
The business facts of the transdermal market are quite attractive.
Although the current worldwide transdermal market is less than
10 percent (approximately $2.2 billion) of the overall $28 billion
drug delivery market; todays market research shows transdermal drug
delivery has recently experienced a healthy annual growth rate of 25
percent. This rate outpaces the percentage of growth in oral drug
delivery (plus 2 percent) and the inhalation market (plus 20 percent).
Long term, pharmaceutical product sales in the drug delivery market
are expected to continue strong growth. Worldwide drug delivery sales
are expected to grow at least 10-12 percent annually over the next
eight years. Because of the reformulation of conventional drugs,
delivery of biotech drugs, genomics, and the use of innovative drug
delivery in early stages of development, the pharmaceutical industry
will drive the drug delivery market to new heights. Transdermal drug
delivery can be expected to play an increasingly significant role in
the success of the expanding drug delivery industry.
3M Website
http://container.pharmalicensing.com/features/disp/936693102_37d4cd6e18626healthcare/manufacturers/dds/pdf/tdd_time_tested.pdf
U.S.
In the article An overview of drug delivery technologies by
Gursharan Moonga (7 September 1999), you can observe the U.S.
transdermal market in the table Drug Delivery Products: 1996 US Sales
by Administration Route below:
Route Sales US$ billion % Share
ORAL 6.10 53
INHALATION 3.10 27
IMPLANT 1.15 10
TRANSDERMAL 0.95 8
OTHERS 2.30 2
Total 11.5 100
Source: Dillon-Read Equity Research
Drug Delivery Industry April 1997
http://container.pharmalicensing.com/features/disp/936693102_37d4cd6e18626
In addition, according to an excerpt of the report Drug Delivery
Systems (published 7/2001 by Freedonia, 266 pages) the Drug Delivery
Systems are broken up like this in the U.S.
Item million US$ 1990 2000 2005
Total 10982 43442 67155
Oral 2467 22030 33300
Parenteral 5567 12585 19805
Inhalation 2797 7400 11385
Transdermal & Implantable 151 1427 2665
U.S. Drug Delivery Systems (published 7/2001 by Freedonia, 266 pages)
http://www.bioportfolio.com/reports/freedonia_DRUG_DEL.htm
Additional information that may interest you:
An interesting article
http://www.psivida.com.au/news/download/Press/dd.pdf
In the U.S. Alternative drug-delivery systems that bring medication
to targeted areas in the body generated $16 billion in U.S. sales in
2000 and are likely to grow to more than $27 billion by year 2005.(..)
Genomics will lead to the identification of a multitude of new
proteins with therapeutic potential. Scientists are now actively
pursuing alternative ways of delivering proteins, particularly
therapeutics for the treatment of chronic conditions. Inhaled,
transdermal, and transmucosal delivery feature strongly.
http://www.sric-bi.com/Explorer/BM.shtml
Search Criteria:
://www.google.com/search?q=transdermal+patch+WORLDWIDE+SALES&hl=es&lr=&ie=UTF-8&start=30&sa=N
://www.google.com/search?sourceid=navclient&hl=es&q=transdermal+delivery+systems+generated+%2A+billion+in+U%2ES%2E+sales
://www.google.com/search?q=U.S.+Transdermal+Drug+Delivery+Market+&hl=es&lr=&ie=UTF-8&start=10&sa=N
://www.google.com/search?hl=es&ie=ISO-8859-1&q=U.S.++Market+for+Transdermal+Drug+Delivery+Systems&btnG=B%FAsqueda+en+Google&lr=
://www.google.com/search?q=transdermal+drug+delivery:+U.S.+sales&hl=es&lr=&ie=UTF-8&start=10&sa=N
://www.google.com/search?q=transdermal+drug+delivery+U.S.+SALES&btnG=B%FAsqueda+en+Google&hl=es&ie=ISO-8859-1
I hope this provides you with the information you are seeking.
Best regards,
Bobbie7-ga |